Pharmacotherapeutic management of sleep disorders in children with neurodevelopmental disorders
- 22 October 2019
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 20 (18) , 2257-2271
Abstract
Introduction: Sleep disturbances are highly prevalent in children with neurodevelopmental disabilities. Without appropriate treatment, sleep disorders can become chronic and last for many years. However, there are no sleep medications approved by the United States Food and Drug Administration and only one has been approved by the European Medicines Agency for pediatric insomnia; thus, most medications are prescribed off-label. Areas covered: In this narrative review, the authors highlight and summarize the most common drugs and supplements used for the treatment of sleep problems in children with neurodevelopmental disabilities. Recommendations are formulated regarding the use of melatonin and melatonin receptor agonists, sedating antidepressants, antipsychotics, antihistamines, gabapentin, clonidine and orexin receptor antagonists, and benzodiazepines and hypnotic benzodiazepine receptor agonists. Expert opinion: The choice of pharmacological agents and their dosage should be individualized taking into consideration multiple factors, including the severity and type of sleep problem and the associated neurological pathology. Melatonin is widely used and safe in children with neurodevelopmental conditions. Gabapentin, clonidine, trazodone, and mirtazapine hold promise but require further study. Supplements (iron, vitamin D, and 5-hydroxytryptophan) might be helpful. Due to the lack of clinical data, there is still uncertainty concerning dosing regimens and tolerability.Keywords
This publication has 154 references indexed in Scilit:
- Parent-reported sleep problems, symptom ratings, and serum ferritin levels in children with attention-deficit/hyperactivity disorder: a case control studyBMC Pediatrics, 2013
- Dual Hypocretin Receptor Antagonism Is More Effective for Sleep Promotion than Antagonism of Either Receptor AlonePLOS ONE, 2012
- Histamine in the regulation of wakefulnessSleep Medicine Reviews, 2011
- Dose finding of melatonin for chronic idiopathic childhood sleep onset insomnia: an RCTPsychopharmacology, 2010
- The Effects of Iron and/or Zinc Supplementation on Maternal Reports of Sleep in Infants from Nepal and ZanzibarJournal of Developmental & Behavioral Pediatrics, 2009
- Abnormal melatonin synthesis in autism spectrum disordersMolecular Psychiatry, 2007
- Improving infant sleep and maternal mental health: a cluster randomised trialArchives of Disease in Childhood, 2007
- Sleep Disturbance and Rage Attacks in Opsoclonus-Myoclonus Syndrome: Response to TrazodoneThe Journal of Pediatrics, 2005
- Toxic clonidine ingestion in childrenThe Journal of Pediatrics, 2005
- Niaprazine vs chlordesmethyldiazepam in sleep disturbances in pediatric outpatients.Pharmacological Research, 1992